Quince Therapeutics's market cap is currently $61.60M. The company's EPS TTM is $-1.247; its P/E ratio is ―; Quince Therapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -322.00K	$ -175.00K	$ -344.00K	$ -332.00K	$ -188.00K
Operating Income	$ -34.62M	$ -52.02M	$ -90.32M	$ -78.89M	$ -39.17M
EBITDA	$ -31.26M	$ -52.02M	$ -89.97M	$ -78.56M	$ -38.98M
Net Income	$ -31.39M	$ -51.66M	$ -89.33M	$ -76.85M	$ -36.79M
Balance Sheet
Cash & Short-Term Investments	$ 75.06M	$ 90.18M	$ 106.80M	$ 133.82M	$ 99.86M
Total Assets	$ 167.90M	$ 103.91M	$ 133.23M	$ 189.47M	$ 124.37M
Total Debt	$ 13.81M	$ 453.00K	$ 1.16M	$ 208.00K	$ 0.00
Net Debt	$ -6.94M	$ -44.13M	$ -68.56M	$ -66.63M	$ -51.21M
Total Liabilities	$ 82.82M	$ 3.32M	$ 14.64M	$ 17.20M	$ 8.89M
Stockholders' Equity	$ 85.08M	$ 100.59M	$ 118.59M	$ 172.26M	$ 115.48M
Cash Flow
Free Cash Flow	$ -18.45M	$ -44.17M	$ -63.11M	$ -50.87M	$ -33.33M
Operating Cash Flow	$ -18.29M	$ -44.04M	$ -62.93M	$ -50.82M	$ -33.28M
Investing Cash Flow	$ -5.76M	$ 18.00M	$ 58.95M	$ -52.43M	$ -17.75M
Financing Cash Flow	$ 143.00K	$ 707.00K	$ 6.81M	$ 118.88M	$ 77.37M

Currency in USD

Quince Therapeutics Earnings and Revenue History

Income Statement >

Quince Therapeutics Debt to Assets

Balance Sheet >

Quince Therapeutics Cash Flow

Cash Flow >

Quince Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing